Trivarx Ltd (AU:TRI) — Market Cap & Net Worth
Market Cap & Net Worth: Trivarx Ltd (TRI)
Trivarx Ltd (AU:TRI) has a market capitalization of $17.14 Million (AU$24.23 Million) as of May 3, 2026. Listed on the AU stock exchange, this Australia-based company holds position #25497 globally and #1154 in its home market, demonstrating a 40.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Trivarx Ltd's stock price AU$0.02 by its total outstanding shares 1153693464 (1.15 Billion). Analyse Trivarx Ltd operating cash flow efficiency to see how efficiently the company converts income to cash.
Trivarx Ltd Market Cap History: 2015 to 2026
Trivarx Ltd's market capitalization history from 2015 to 2026. Data shows change from $4.45 Billion to $17.14 Million (-42.57% CAGR).
Trivarx Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Trivarx Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
13.74x
Trivarx Ltd's market cap is 13.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.71 Billion | $18.50K | -$5.82 Million | 308530.49x | N/A |
| 2017 | $5.11 Billion | $23.10K | -$9.79 Million | 221418.34x | N/A |
| 2018 | $333.06 Million | $204.88K | -$16.30 Million | 1625.63x | N/A |
| 2019 | $158.61 Million | $364.63K | -$6.59 Million | 434.99x | N/A |
| 2020 | $130.61 Million | $133.50K | -$4.70 Million | 978.35x | N/A |
| 2021 | $89.79 Million | $101.66K | -$1.49 Million | 883.32x | N/A |
| 2022 | $32.65 Million | $40.04K | -$12.72 Million | 815.54x | N/A |
| 2023 | $24.49 Million | $22.07K | -$3.12 Million | 1109.42x | N/A |
| 2024 | $13.06 Million | $893.31K | -$1.24 Million | 14.62x | N/A |
| 2025 | $15.51 Million | $1.13 Million | -$943.23K | 13.74x | N/A |
Competitor Companies of TRI by Market Capitalization
Companies near Trivarx Ltd in the global market cap rankings as of May 3, 2026.
Key companies related to Trivarx Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #926 globally with a market cap of $28.21 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #2225 globally with a market cap of $10.06 Billion USD ( AU$14.22 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2339 globally with a market cap of $9.34 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2447 globally with a market cap of $8.82 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #926 | Veeva Systems Inc Class A | NYSE:VEEV | $28.21 Billion | $171.60 |
| #2225 | Pro Medicus Ltd | AU:PME | $10.06 Billion | AU$136.16 |
| #2339 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.34 Billion | $55.00 |
| #2447 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $8.82 Billion | $52.58 |
Trivarx Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Trivarx Ltd's market cap moved from $4.45 Billion to $ 17.14 Million, with a yearly change of -42.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$17.14 Million | +10.53% |
| 2025 | AU$15.51 Million | +18.75% |
| 2024 | AU$13.06 Million | -46.67% |
| 2023 | AU$24.49 Million | -25.00% |
| 2022 | AU$32.65 Million | -63.64% |
| 2021 | AU$89.79 Million | -31.25% |
| 2020 | AU$130.61 Million | -17.65% |
| 2019 | AU$158.61 Million | -52.38% |
| 2018 | AU$333.06 Million | -93.49% |
| 2017 | AU$5.11 Billion | -10.39% |
| 2016 | AU$5.71 Billion | +28.33% |
| 2015 | AU$4.45 Billion | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Trivarx Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.14 Million USD |
| MoneyControl | $17.14 Million USD |
| MarketWatch | $17.14 Million USD |
| marketcap.company | $17.14 Million USD |
| Reuters | $17.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Trivarx Ltd
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more